Track the 강스템바이오텍 share price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 강스템바이오텍 has published 35 reports. Market capitalisation: €210.7bn. The latest transaction was reported on 3 April 2026 (Purchase). Among the most active insiders: 세종. All data is free.
35
Insider Decl.
n/a
Thresholds
n/a
17 ops.
Buy Volume
n/a
2 ops.
Sell Volume
5Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26,628 of 29,063 companies
20.1
score / 100
Value
21
Quality
19
FCF yld-5.9%
Earn yld-5.0%
EV/EBITDA·
ROE-48%
Gross mgn24%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.